DSP-4

Suppliers

Names

[ CAS No. ]:
40616-75-9

[ Name ]:
DSP-4

[Synonym ]:
MFCD00043241
N-[(2-bromophenyl)methyl]-2-chloro-N-ethylethanamine,hydrochloride
DSP-4 N-Ethyl-N-(2-chloroethyl)-2-bromobenzylamine hydrochloride

Chemical & Physical Properties

[ Density]:
1.338g/cm3

[ Boiling Point ]:
276.7ºC at 760 mmHg

[ Molecular Formula ]:
C11H16BrCl2N

[ Molecular Weight ]:
313.06100

[ Exact Mass ]:
310.98400

[ PSA ]:
3.24000

[ LogP ]:
4.31180

[ Index of Refraction ]:
1.551

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DP1726100
CHEMICAL NAME :
Benzylamine, o-bromo-N-(2-chloroethyl)-N-ethyl-, hydrochloride
CAS REGISTRY NUMBER :
40616-75-9
LAST UPDATED :
198506
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C11-H15-Br-Cl-N.Cl-H
MOLECULAR WEIGHT :
313.09

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
300 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
APSXAS Acta Pharmaceutica Suecica. (Apotekarsocieteten-Farmacevtiska Foereningen, Box 1136, S-111, 81 Stockholm, Sweden) V.1- 1964- Volume(issue)/page/year: 10,29,1973
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
60 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
APSXAS Acta Pharmaceutica Suecica. (Apotekarsocieteten-Farmacevtiska Foereningen, Box 1136, S-111, 81 Stockholm, Sweden) V.1- 1964- Volume(issue)/page/year: 10,29,1973

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
DP1726100

[ HS Code ]:
2921499090

Customs

[ HS Code ]: 2921499090

[ Summary ]:
2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats.

CNS Neurosci. Ther. 20(7) , 671-8, (2014)

Serotonin (5-HT) neurons mediate the ectopic release of dopamine (DA) induced by L-DOPA in the Parkinsonian brain. We hypothesized that the participation of noradrenalin transporters (NET) in the clea...

c-Fos activity mapping reveals differential effects of noradrenaline and serotonin depletion on the regulation of ocular dominance plasticity in rats.

Neuroscience 235 , 1-9, (2013)

The roles of the central noradrenergic and serotonergic system in the activity-dependent regulation of ocular dominance plasticity have been a contentious issue. Using c-Fos activity mapping, we have ...

Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.

Neuroscience 202 , 424-33, (2012)

Parkinson's disease (PD) is characterized by a degeneration of dopaminergic neurons and also by a degradation of noradrenergic neurons from the locus coeruleus and serotonergic neurons from the dorsal...


More Articles

Related Compounds

  • N-[(2-bromophenyl)methyl]-2-chloro-N-ethylethanamine
  • dfsp,dsp
  • Quinoline, 4,8-dinitro-, 1-oxide
  • 2,4,6,7-tetramethyl-2,6,7-triaza-1-phosphabicyclo[2.2.2]octane
  • 2,4(1H,3H)-Pyrimidinedione,6-[(2,6-dimethylphenyl)amino]-
  • 1,4-bis(5-bromothiophen-2-yl)butane-1,4-dione